Methods that we use and develop encompass: PCR, reverse transcription PCR, real time PCR, methylation specific PCR followed by sequencing, DNA microarray and bisulfite genomic sequencing, ELISA/LFA immunoassay and proteomic assay. We have analyzed genetic, epigenetic, genomic and proteomic characteristics (we call this “multiplex molecular analysis”) in a procedure called “cansolution”
This is an example of our cancer chip. Goodgene has developed a multiplex PCR based DNA microarray (DNA chip) technology, by which it is possible to analyze , expression and methylation of more than hundreds of cancer-related key genes.
NOT AUTHORIZED OR CLEARED FOR CLINICAL USE IN THE USA, RESEARCH USE ONLY
Loading...
Reload document
Open in new tab